van Duivenvoorde Leonie M, Dorris Martha L, Satumtira Nimman, van Tok Melissa N, Redlich Kurt, Tak Paul P, Taurog Joel D, Baeten Dominique L
Academic Medical Center and University of Amsterdam, Amsterdam, The Netherlands.
Arthritis Rheum. 2012 Oct;64(10):3210-9. doi: 10.1002/art.34600.
Inhibition of inflammation and destruction, but not of osteoproliferation, in patients with spondylarthritis (SpA) treated with anti-tumor necrosis factor raises the question of how these three processes are interrelated. This study was undertaken to analyze this relationship in a rat model of SpA.
Histologic spine and joint samples from HLA-B27/human β(2) -microglobulin (hβ(2) m)-transgenic rats were analyzed for signs of spondylitis and destructive arthritis and semiquantitatively scored as showing mild, moderate, or severe inflammation.
In rats exhibiting spondylitis, mildly inflamed sections displayed lymphocyte infiltration in connective tissue adjacent to the junction of the anulus fibrosus and vertebral bone but not at the enthesis. Moderately inflamed tissue samples contained osteoclasts eroding bone outside the cartilage end plate. In sections from rats with severe inflammation, the cartilage end plate and underlying bone marrow were also affected. End-stage disease was characterized by complete destruction of the intervertebral disc and vertebrae, with ongoing infiltration. Osteoproliferation was not observed in samples from rats with no or mild inflammation, but was present at the edge of the vertebrae in sections with moderate inflammation and persisted during severe inflammation and end-stage destruction. Osteoproliferation occurred at the border of inflammation, at a distance from bone destruction. A strong correlation between the extent of inflammation, destruction, and osteoproliferation was observed. Sections from rats with arthritis displayed a similar pattern of synovial inflammation associated with bone destruction, and simultaneous but topographically distinct osteoproliferation starting from the periosteum.
SpA in B27/hβ(2) m-transgenic rats is characterized by destructive inflammatory pannus tissue rather than by enthesitis or osteitis. Destruction and osteoproliferation occur simultaneously but at distinct sites in joints with moderate to severe inflammation.
抗肿瘤坏死因子治疗脊柱关节炎(SpA)患者时,炎症和破坏受到抑制,但骨增殖未受抑制,这引发了这三个过程如何相互关联的问题。本研究旨在分析SpA大鼠模型中的这种关系。
对HLA-B27/人β2-微球蛋白(hβ2m)转基因大鼠的脊柱和关节组织样本进行组织学分析,以寻找脊柱炎和破坏性关节炎的迹象,并进行半定量评分,分为轻度、中度或重度炎症。
在表现出脊柱炎的大鼠中,轻度炎症切片显示在纤维环与椎骨交界处相邻的结缔组织中有淋巴细胞浸润,但在附着点处未出现。中度炎症组织样本中含有侵蚀软骨终板外骨骼的破骨细胞。在严重炎症大鼠的切片中,软骨终板和下方的骨髓也受到影响。终末期疾病的特征是椎间盘和椎体完全破坏,并伴有持续的浸润。在无炎症或轻度炎症大鼠的样本中未观察到骨增殖,但在中度炎症切片的椎体边缘出现骨增殖,并在严重炎症和终末期破坏期间持续存在。骨增殖发生在炎症边界,与骨破坏有一定距离。观察到炎症、破坏和骨增殖程度之间存在强烈相关性。患有关节炎大鼠的切片显示出与骨破坏相关的类似滑膜炎症模式,以及从骨膜开始的同时但在地形上不同的骨增殖。
B27/hβ2m转基因大鼠的SpA特征为破坏性炎性血管翳组织,而非附着点炎或骨炎。破坏和骨增殖同时发生,但在中度至重度炎症的关节中位于不同部位。